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ABSTRACT 
 
Some clinicians are under the impression that there is little or no evidence to support the 
use of honey as a wound dressing. This impression is reinforced by it being concluded 
in systematic reviews that the evidence is not of a high standard. But likewise the 
evidence for modern wound dressing products is of not of a high standard. For 
evidence-based medicine to be practised in wound care, when deciding which product to 
use to dress a wound it is necessary to compare the evidence that does exist, rather 
than be influenced by advertising and other forms of sales promotion. To allow sound 
decisions to be made, this review has covered the various reports that have been 
published on the clinical usage of honey. Positive findings on honey in wound care have 
been reported from 17 randomised controlled trials involving a total of 1965 participants, 
and 5 clinical trials of other forms involving 97 participants treated with honey. The 
effectiveness of honey in assisting wound healing has also been demonstrated in 16 
trials on a total of 533 wounds on experimental animals. There is also a large amount of 
evidence in the form of case studies that have been reported. Ten publications have 
reported on multiple cases, totalling 276 cases. There are also 35 reports of single 
cases. These various reports provide a large body of evidence to support honey having 
the beneficial actions of clearing and preventing wound infection, rapidly debriding 
wounds, suppressing inflammation and thus decreasing oedema, wound exudate and 
hypertophic scarring, and stimulating the growth of granulation tissue and 
epithelialisation. It has been shown to give good results on a very wide range of types of 
wound. Clinicians should look for the clinical evidence that exists to support the use of 
other wound care products to compare with the evidence that exists for honey. 
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There is a rapidly increasing interest in the use of honey as a wound dressing, but it is 
common to hear clinicians express the opinion that there is no evidence to support the 
use of honey as a wound dressing. However, the impression upon which this opinion is 
based is most likely to be a reflection of the scarcity of advertising and other commercial 
promotion of honey for wound care relative to that of other wound care products. Even 
where reviews of clinical evidence for the use of honey have been published, a negative 
impression is often obtained from consulting these, as the conclusions stated are that 
the evidence is of low quality and/or that there is a need for more evidence.1-6 But the 
myriad of advertisements for modern wound dressings possibly blinds people to the fact 
that only small, poor-quality trials exist to support the use of these products.7 For 
example, if the PubMed database is searched for evidence to support the use of 
nanocrystalline silver dressings, which are very heavily promoted, it can be seen that 
there is in fact very little clinical evidence that has been published. A recent systematic 
review of publications on the use of advanced dressings in the treatment of pressure 
ulcers has found that their generalised use in the treatment of pressure ulcers is not 
supported by good research evidence.8 In evidence-based medicine decisions should be 
made on the basis of the available evidence: where randomised controlled trials of the 
highest quality have not been conducted, then it is necessary to consider evidence of a 
lower quality. It is for these reasons that this review has been written, to allow clinicians 
to see the large amount of evidence that exists for the effectiveness of honey as a 
wound dressing. By comparing this with the evidence for other wound-care products 
clinicians can then judge for themselves the relative merits of honey as a treatment 
option for wounds. 
The literature cited was found by searching the PubMed, BIOSIS and ISI Web of 
Science databases for the term ”honey”. Also, literature not included in the databases 
was found from citations in papers that were. Excluded were papers where honey was 
used in a mixture with other therapeutic substances, papers giving brief reports on the 
use of honey on cases where there was insufficient information on the cases given for 
the reader to judge if the positive outcomes were the result of honey being more 
effective than the prior treatment, and papers that were expressions of opinion rather 
than reports of treatment of wounds with honey. Conference presentations were also 
excluded. 
 
CLINICAL EVIDENCE 
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Many randomised controlled trials have been carried out comparing honey with various 
other wound treatments. These trials and the results obtained from them are 
summarised in Table 1. Other clinical trials have been conducted where the form of the 
trial has been other than a randomised controlled trial. In some of these the results for 
the group of patients treated with honey were compared retrospectively with those from 
the control treatment. In others the patients were crossed over to treatment with honey 
after a period of the treatment normally used for that type of wound. The details of these 
trials and the results obtained from them are summarised in Table 2. Some of the case 
studies reported for single cases have also involved a comparative study. In these the 
patient has had multiple wounds, so honey could be used on one side and the usual 
treatment on the other. The details of these are summarised in Table 3. 
There have also been many non-comparative studies reported on the use of 
honey as a wound dressing. Since many of these cases were not responding to 
standard treatment for quite some time before dressing with honey was commenced, 
these provide evidence that is somewhat like that from a cross-over trial, although these 
studies involved no reverse change in treatment like would be done in a cross-over trial. 
Some of these studies have been with multiple cases. The details of these are 
summarised in Table 4. The details of studies of single cases are summarised in Table 
5. 
 
EVIDENCE FROM ANIMAL EXPERIMENTS 
 
Many studies have been carried on the effectiveness of honey in promoting the healing 
of standardised wounds created on experimental animals. These experiments have not 
only allowed there to be much more closely comparable controls in trials, but also have 
allowed histological examination of the healing wounds to provide additional data 
besides the usual measurements of decrease in wound size and time to heal. These 
experiments and the results obtained from them are summarised in Table 6. 
 
DISCUSSION 
 
The evidence presented in this review amply demonstrates that honey, the oldest wound 
dressing material known to medicine, can give positive results where the most modern 
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products are failing. Because people generally are unaware of the historical usage of 
honey as a wound dressing, or know only of its ancient usage, its clinical usage is 
presumed to be a new development or something that has been “rediscovered”.9 
However, a look at the reference list at the end of this paper will reveal reports of clinical 
usage published in the 1950s,10,11 1960s,12 1970s,13-16 and 1980s17-23 as well as the 
rapidly increasing number since it apparent “rediscovery”. Clinicians need to decide if 
modern wound-care products are likely to give better results than this long-established 
wound dressing material. 
The evidence presented here that supports the use of honey in wound care 
includes evidence from many clinical trials. However, none of the findings from these 
trials would be considered to be evidence of the very highest level, because even 
though they may have been randomised controlled trials they have not been double-
blind. It is near impossible to conduct a double-blind trial of honey as a wound dressing, 
because of the difficulty of keeping obscured from the patients that a material as 
recognisable as honey is being used. Even if honey is applied in the form of a 
manufactured dressing, its aroma is immediately recognised. For this reason there is 
always the possibility that positive results achieved with honey will be partly due to a 
placebo effect. 
However, there are trials and case studies in which the honey and the comparative 
treatment were used simultaneously on the same patient. These demonstrate that 
positive results achieved with honey are not just a placebo effect. One of these was a 
prospective randomised controlled trial of honey on split-thickness skin graft donor 
sites24 (the last item in Table 1). On patients in this trial who had single donor sites 
(three groups of 14 patients), half of the donor site was treated with honey and half with 
the comparative treatment. On patients with two donor sites (three groups of 15 
patients) one of the donor sites was treated with honey and one with the comparative 
treatment. (Honey was compared with three controls, saline-soaked gauze, paraffin 
gauze and a hydrocolloid.) In that trial, the significantly faster healing rates and lower 
pain scores achieved with honey compared with saline-soaked gauze and paraffin 
gauze clearly would have been due to physical effects of the honey and not to 
psychosomatic effects. Further evidence of a similar nature is seen in the results 
achieved in the case studies summarised in Table 3, although unlike with the trial with 
the skin graft donor sites where the wounds being compared were of a standard nature, 
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there is a possibility the wounds given different treatment for comparison may not have 
been identical when treatment was started. 
The most convincing evidence for the results with honey not being due to a 
placebo effect comes from the many studies that demonstrated the effectiveness of 
honey on standard wounds inflicted on experimental animals. Although the participants 
in these trials may well have been able to detect by smell that honey was being used 
they would not have had any psychosomatic effects on healing resulting from beliefs 
that natural products would be more effective, or from hearing via the news media of the 
effectiveness of honey in wound treatment. 
Another factor that many say may be the reason why honey gives good results in 
individual cases studied is that wound healing improves whenever wounds are receiving 
more attention, or that the prior treatment was less than ideal. However, in many of the 
cases summarised in Table 5 the wounds were receiving specialist care before honey 
was used. They changed to healing from non-healing only when treatment with honey 
was commenced. In many of these cases the wounds were not responding to best 
practice with modern dressings, although a recent systematic review of the evidence for 
the efficacy of modern wound dressings in the treatment of pressure ulcers has 
concluded that there is no evidence that these are any better than saline-soaked 
gauze.8 
Further evidence to support the use of honey as a wound dressing comes from 
laboratory studies that have clearly demonstrated that honey has bioactivities that would 
be beneficial in wound care. In work with cultures of leukocytes, honey has been shown 
to stimulate cytokine production by monocytes.25,26 The release of cytokines is what 
initiates the tissue repair process as well as the immune response to infection. Also, 
simulation by honey of other aspects of the immune response, the proliferation of B- and 
T-lymphocytes and the activity of phagocytes, has been shown.27 Additional to this work 
with cells in culture, it has been demonstrated that honey stimulates the production of 
antibodies in mice in response to antigens from Escherichia coli.28 These findings 
suggest that part of the effectiveness of honey in clearing and preventing infection in 
wounds that is so widely seen in the clinical evidence may be due to enhancement of 
the body’s own immunity as well as being due to the antibacterial activity of honey. 
The number of publications on laboratory studies showing that honey has 
antibacterial activity with a very broad spectrum is very large.29 But what is often not 
taken into account is that honeys can vary as much as 100-fold in the potency of their 
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antibacterial activity.30 More recent publications have reported on the sensitivity of 
various species of bacteria to honey with antibacterial potency near the median level 
found in surveys of large numbers of samples. (This level is a little below that of the 
various honey wound-care products now on sale manufactured from Leptospermum 
honey, but there are other wound-care products manufactured from honeys not selected 
to have high levels of antibacterial activity.31) Laboratory studies with Leptospermum 
(manuka) honey with antibacterial potency near the median level have shown the MIC 
(minimum inhibitory concentration, i.e. the concentration down to which honey could be 
diluted by wound exudate and still prevent bacterial growth) to be 2–3% for 
Staphylococcus aureus,32 3.3–4% for coagulase-negative staphylococci,33 5.5–9% for 
pseudomonads,34,35 2.7–3% for MRSA,36 and 3.8–5% for VRE.36. (The effectiveness of 
honey in clinical usage in clearing infection with MRSA37-41 and VRE40 has been 
reported.) The slow clearance of infection, or failure to clear infection, in some of the 
cases reported may well reflect the use of honey with a low antibacterial potency. For 
example, this may have been the case in the randomised controlled trial where honey 
was found to be less effective than early tangential excision followed by autologous skin 
grafting in controlling infection in the treatment of burns.42 The same author, publishing 
results comparing the MIC values for various types of honey available locally, reported 
that the MIC for the most potent honey against Staphylococcus aureus was 20–25%,43 
which means that the honey had only about one tenth of the antibacterial potency of the 
Leptospermum honey used in wound-care products now on sale. 
Another reason for variability in results may have been that the honey in some 
cases was not being kept in place on the wound. The difficulty of achieving this has 
been commented on.44,45 If the honey is flushed out of the dressing by wound exudate 
then its various bioactivities cannot be having any effect on the wound. A case which 
may be an example of this is where infection in a leg ulcer was reported to recur when 
compression was commenced.46 Here it was noted that there was a problem with 
dressings adhering, which is a clear indication that honey has been flushed out of the 
dressing by wound exudate.47 A similar occurrence was reported where honey-
impregnated tulle dressings were being used.48 These have very little absorbency so 
honey is easily flushed from them. It was noted in this case that the dressings became 
saturated with exudate within one hour. In another case where poor progress was 
occurring with honey it was found that much better progress with healing occurred when 
more frequent changes of the dressings were made.49 
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It has been noted that if sufficient honey is kept in place, by applying it by way of 
impregnated dressings and changing these frequently enough, then its anti-
inflammatory activity will reduce the amount of exudate and thus remove the need for 
frequent dressing changes.47 There is a very large amount of evidence for honey having 
significant anti-inflammatory activity. As well as the evidence that has come from the 
many clinical observations summarised in this review there is evidence from histological 
observation of biopsy samples taken in a clinical trial of honey on burns,50 and from 
biochemical assays of indicators of inflammation in other clinical trials on burns.51,52 One 
of these biochemical studies was in the form of a randomised controlled trial with 60 
patients, comparing honey with silver sulfadiazine, and it was demonstrated that honey 
decreased oxidative stress by mopping up the free radicals arising from burns.52 There 
is also histological evidence for the anti-inflammatory activity of honey from some of the 
studies on experimental animals summarised in Table 6. In some of the experimentally 
induced burns there was no infection evident, yet honey still brought about a decrease in 
inflammation. This indicates that the anti-inflammatory activity of honey is a direct action 
and not a secondary consequence of removal of infection through its antibacterial 
activity. This is confirmed also by honey giving a positive result in the standard guinea-
pig wrist stiffness test for anti-inflammatory activity.53 That honey has a direct anti-
inflammatory activity is also indicated by it being found that honey was as effective as 
prednisolone in a trial on induced colitis in rats,54 and by it being found to give a highly 
significant (p<0.001) reduction in peritoneal adhesions following surgery on the caecum 
and ileum in another trial on rats.55 A laboratory study also demonstrated a direct anti-
inflammatory activity in honey, as honey was shown to significantly (p<0.001) decrease 
the amount of reactive oxygen intermediates released from monocytes in culture that 
had been stimulated with Escherichia coli lipopolysachharide. 
 
CONCLUSIONS 
 
There is a large body of evidence to support the use of honey as a wound dressing for a 
wide range of types of wound. Its antibacterial activity rapidly clears infection and 
protects wounds from becoming infected, thus it provides a moist healing environment 
without the risk of bacterial growth occurring. It. also rapidly debrides wounds and 
removes malodour. Its anti-inflammatory activity reduces oedema and exudate, and 
prevents or minimises hypertrophic scarring. It also stimulates the growth of granulation 
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tissue and epithelial tissue so that healing is hastened. Furthermore, it creates a non-
adherent interface between the wound and the dressing so that dressings may be easily 
removed without pain or damage to newly re-grown tissue 
The barrier to using honey that has existed for many clinicians who have been 
constrained to using only licensed products has been removed now that honey is 
available in the form of various sterile products licensed for use in wound care. To 
practise evidence-based medicine, clinicians involved in wound care thus should check 
what evidence exists for other wound dressing products they may be considering using, 
and weigh this up against the evidence that exists to support the use of honey. 
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Table 1. Randomised controlled trials that have been carried out on honey as a wound dressing 
 
Type of 
wound 
Control  
treatment 
No. in 
trial 
Results 
Honey cf control 
Statistics Other findings Ref. 
no. 
Proportion of wounds becoming 
sterile within 7 days: 91% cf 7% 
p < 0.001 
Mean time that healthy granulation 
tissue first observed: means 7.4 cf 
13.4 days 
Not given 
Proportion of wounds healing 
within 15 days: 87% cf 10% 
Not given 
Superficial 
burns 
Silver 
sulfadiazine 
104 
Mean healing time: 9.0 days cf 
24.6 days 
p < 0.001 
Honey gave better relief of pain, less 
irritation of the wound, less exudation, a 
lower incidence of hypertrophic scar and 
post-burn contracture, acceleration of 
epithelialisation, a chemical debridement 
effect and removal of offensive smell. 
56 
Mean healing time: 10.8 days cf 
15.3 days 
p < 0.001 Fresh 
partial-
thickness 
burns 
OpSite® 92 
Cases infected after 8 days: 8 cf 17 p < 0.001 
Honey gave debridement and 
deodorisation, a soothing effect, and ease 
of removal of dressings with little pain. 
57 
Mean healing time: 9.4 days cf 
17.5 days 
p < 0.001 
Proportion of patients with residual 
scars: 8% cf 16.6% 
p < 0.001 
Fresh 
partial-
thickness 
burns 
Amniotic 
membrane 
64 
Number of cases infected after 7 
days: 4 cf 11 
p < 0.001 
 58 
Partial-
thickness 
burns 
Conventional 
(90 with 
Vaseline 
900 Mean healing time: 9 days cf 13.5 
days 
Not given  59 
 18 
Proportion of wounds infected: 
5.5% cf 12% 
Not given 
Proportion of cases resulting in 
scars: 6.2% cf 20% 
Not given 
Mean healing time: 10.4 days cf 
16.2 days 
p < 0.001 Fresh 
partial-
thickness 
burns 
Boiled potato 
peel 
82 
Proportion of those with positive 
swab cultures becoming sterile 
within 7 days: 100% cf 0% 
p < 0.001 
 60 
Proportion showing epithelialisation 
by 7th day: 84% cf 72%;  
by 21st day: 100% cf  84% 
p < 0.001 Superficial 
burns 
Silver 
sulfadiazine 
50 
Proportion showing evidence of 
reparative activity (on histological 
examination of biopsy samples): 
 on Day7: 80% cf 52% 
 on Day21: 100% cf 84% 
p < 0.005 
Honey gave early subsidence of acute 
inflammatory changes, better control of 
infection and quicker wound healing.  
There was eschar in 60% of the cases 
treated with silver sulfadiazine, none with 
honey. 
 
With silver sulfadiazine, 4 of the superficial 
burns converted to deep burns requiring 
skin grafting, none with honey. 
50 
Mean percentage blood volume 
replaced: 21% cf 35% 
p<0.01 
Mean period antibiotics needed: 32 
days cf 16 days 
p<0.001 
Moderate 
burns, half 
of the total 
burn area 
being full-
thickness 
Tangential 
excision 3–6 
days post-
burn, then 
skin grafting 
50 
Proportion of swab cultures 
positive: 34% cf 10% 
p<0.05 
Skin grafting was required on only 11 of the 
25 treated with honey cf all of the 
tangentially excised group. 
42 
 19 
Mean length of hospital stay: 46 
days cf 21 days 
p<0.001 
Proportion with excellent or good 
wound appearance after 3 months: 
55% cf 92% 
p<0.01 
Mean healing time:15.4 days cf 
17.2 days 
p<0.001 
Number of swab cultures positive 
after 7 days: 4 (from 44 at start) cf 
42 (from 42 at start) 
p<0.001 
Lipid peroxidation (a measure of 
inflammation): 
 4.3 cf 5.3 on day 7 
 3.8 cf 4.4 on day 14 
 3.2 cf 4.1 on day 21 
 
 
p<0.01 
p<0.01 
p<0.005 
Moderate 
burns, 1/6th 
total burn 
area being 
full-
thickness 
Silver 
sulfadiazine 
100 
Mean length of hospital stay: 22.0 
days cf 32.3 days 
p<0.005 
With honey, 4 required grafting cf 11 with 
silver sulfadiazine, and there was one case 
of contractures cf 5 with silver sulfadiazine. 
51 
Mean healing time: 11.0 days cf 
16.1 days 
p<0.001 
Mean time to form healthy 
granulation: 6.7 days cf 12.8 days 
Not given 
Paediatric 
burns 
Silver 
sulfadiazine 
64 
Number of swab cultures positive 
after 7 days: 24 (from 25 at start) cf 
21 (from 24 at start) 
p<0.001 
There were 2 cases of contractures with 
honey cf 5 with silver sulfadiazine. 
 
Honey gave a decrease in oedema and 
exudate, and no eschar. 
61 
 20 
Superficial 
burns 
Silver 
sulfadiazine 
50 100% of cases healed in 10 days 
cf 70% in 15 days 
Not given Honey gave early subsidence of acute 
inflammation, and better control of infection. 
Honey reduced the period of hospital stay 
and expenses by 30%. 
62 
Mean time to get negative swab 
cultures: 6 days cf 14.8 days 
p<0.05 
Mean number of days antibiotics 
were required: 6.88 cf 15.4 
p<0.05 
Mean healing time:10.73 days cf 
22.04 days 
p<0.05 
Mean size of post-operative scars: 
3.62 mm cf 8.62 mm 
p<0.05 
Severe 
post-
operative 
wound 
infections 
following 
abdominal 
surgey 
Washing 
wounds with 
70% ethanol 
then applying 
povidone-
iodine 
50 
Mean period of hospitalisation 
required: 9.36 days cf 19.91 days 
p<0.05 
With honey there was mild wound 
dehiscence in 4 cases, with no need for re-
suturing: in the control group there was 
wound dehiscence in 12 cases, 6 requiring 
re-suturing under general anaesthetic. 
63 
Proportion on Day 7 with clean 
wounds: 100% cf 65.5% 
p=0.007 
Proportion on Day 7 with 
granulating wounds: 100% cf 50% 
p<0.001 
Proportion on Day 7 with 
epithelialising wounds: 86.9% cf 
35% 
p=0.001 
Surgically 
drained 
pyomyositis 
abscesses 
EUSOL-
soaked 
gauze 
32 
(43 
wounds) 
Proportion on Day 21 with 
complete epithelialisation: 86.9% cf 
55.0% 
p=0.047 
 64 
 21 
Mean length of hospital stay: 16.08 
days cf 18.61 days 
(medians 14 days cf 22 days) 
p = 0.019 
Mean reduction in ulcer size: 
27.0% cf 35.5% 
Not 
significant 
Chronic leg 
ulcers 
(mean 
duration of 
56.5 
months) 
Phenytoin 
paste 
50 
Mean pain score (on a scale of 1 to 
10): 1.8 cf 3.6 
Not 
significant 
 65 
Proportion healed in 10 days:100% 
cf 70% 
p<0.05 Pressure 
ulcers on 
orthopaedic 
patients 
Saline-
soaked 
gauze 
40 
Mean healing time for ulcers that 
healed in 10 days: 8.2 days cf 9.9 
days 
p<0.001 
 66 
Exit sites of 
central 
venous 
catheters 
Povidone-
iodine 
49 Incidences of blood-stream 
infections: 12 cf 19 episodes per 
1000 catheter-days 
Not 
significant 
 67 
Exit sites of 
tunnelled, 
cuffed 
central 
venous 
catheters 
Mupirocin 101 Incidences of catheter-associated 
bacteraemias: 0.97 cf 0.85 
episodes per 1000 catheter-days 
Not 
significant 
 68 
Split-
thickness 
skin graft 
Saline-
soaked 
gauze: also 
87 
(174 
sites 
Mean healing time: 9.1 days cf 
13.2 days with saline 
p<0.05 Leakage occurred on 22 dressing changes 
with the hydrocolloid: no fluid accumulated 
under the honey dressing. 
24 
 22 
Mean healing time: 9.4 days cf 
12.4 days with paraffin,  
p<0.001 
Mean healing time: 9.6 cf 9.4 days 
with hydrocolloid 
Not 
significant 
Mean pain scores, honey cf saline: 
 Day 1:  4.8 cf 7.2 
 Day 2:  2.9 cf 4.2 
 Day 3:  2 cf 3.1 
p<0.05 
Mean pain scores, honey cf 
paraffin: 
 Day 1:  4.6 cf 6.7 
 Day 2:  3.2 cf 3.9 
 Day 3:  1.8 cf 2.8 
p<0.05 
Mean pain scores, honey cf 
hydrocolloid: 
 Day 1:  4.4 cf 4 
 Day 2:  2.9 cf 2.6 
 Day 3:  1.8 cf 1.6 
Not 
significant 
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Table 2. Other types of clinical trials that have been carried out on honey as a wound dressing 
 
Type of 
wound 
Form of trial No. in 
trial 
Results 
 
Statistics Other findings Ref. 
no.  
Disrupted 
abdominal 
wounds from 
Caesarean 
section 
Results from 15 patients 
treated with honey 
application and wound 
approximation by 
micropore tape were 
compared retrospectively 
with 19 similar cases who 
had their dehisced 
wounds cleaned with 
hydrogen peroxide and 
Dakin solution and packed 
with saline-soaked gauze 
prior to resuturing under 
general anaesthesia. 
15 cf 
19 
Period of hospitalisation 
required: 2 - 7 days (mean 4.5) 
with honey cf  9 - 18 days 
(mean 11.5) with control 
Not given With honey, 11 healed within 7 
days, the other 4 within 2 weeks. 
 
With honey, slough and necrotic 
tissue were replaced by 
granulation and advancing 
epithelialisation within 2 days, 
wounds were made odourless 
and sterile within 1 week, and no 
re-suturing was required. 
69 
 24 
Fournier's 
gangrene 
(necrotising 
fasciitis on 
the scrotum) 
20 consecutive cases of 
Fournier's gangrene 
managed conservatively 
with honey plus systemic 
antibiotics (oral 
amoxicillin/clavulanic acid 
and metronidazole), were 
compared with 21 cases 
managed in the same 
period by another 
consultant, using surgical 
debridement. 
41 With honey, within 1 week 
malodour, oedema and 
discharge had subsided, all 
necrotic tissues had separated, 
rapid epithelialisation was 
occurring. 
 
Within 1 week with honey all 
swabs were negative: there was 
no need to change from the 
routine antibiotics to ones to 
which the bacteria were found to 
be sensitive, as was done with 
the surgically debrided cases. 
Not given A second operation for secondary 
suturing was needed for all cases 
surgically debrided, with plastic 
reconstruction needed for two of 
these With honey no surgery was 
needed, and most healed with 
very little or no scars. 
 
3 deaths occurred in the 
surgically treated group, none in 
the honey-treated group. 
70 
 25 
Large 
infected 
surgical 
wounds on 
infants 
Treatment was crossed 
over to honey dressings 
after wounds had failed to 
heal with treatment of at 
least 14 days using 
intravenous antibiotics 
(vancomycin plus 
cefotaxime, subsequently 
changed according to 
bacterial sensitivity), 
fusidic acid ointment, and 
wound cleaning with 
aqueous 0.05% 
chlorhexidine solution. 
9 After starting dressing with 
honey a marked clinical 
improvement was seen in all 
cases after 5 days, and all 
wounds were closed, clean and 
sterile after 21 days.  
Not given Six of the patients had systemic 
antibiotic treatment discontinued 
when treatment with honey 
started. 
71 
Pain decreased from an 
average McGill score of 1.6 to 
1.08 in 12 weeks. 
p<0.02 
Linear decrease in pain with 
time 
p<0.001 
Decrease in pain correlated with 
reduction in wound size 
p<0.05 
Venous leg 
ulcers, non-
healing after 
at least 12 
weeks of 
compression 
 
Treatment was crossed 
over to honey dressings 
used under compression 
from standard treatment 
for venous ulcers  
40 
Decrease in pain correlated with 
healing rate 
p<0.05 
In the 12 week study period, 
complete healing occurred in 7 
cases, with a significant reduction 
in ulcer size for the rest (mean 
reduction 32%). 
 
There was a high level of patient 
satisfaction with honey dressings. 
72 
 26 
The 26 malodorous wounds 
decreased in odour mean score 
(on a scale of 1 to 3) in two 
weeks from 1.58 to 0.69. 
p<0.001 
Burns A review of all the burns 
cases in a hospital over 
the preceding 5 years 
156 90.5% of the cases were treated 
with silver sulfadiazine, 8.5% 
with honey: the outcomes were 
similar. 
Not given  73 
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Table 3. Case studies on the use of honey as a wound dressing where a comparison with other treatments was conducted on multiple wounds 
within single cases 
 
Type of wounds Status of wounds before 
using honey 
Comparison Results Ref. 
no.  
Multiple chronic leg 
ulcers, on both legs 
20 year history of multiple 
ulcers on the legs and feet 
resulting from chronic venous 
hypertension with secondary 
lymphoedema  
The ulcers on one leg 
were dressed with honey, 
those on the other leg with 
Aquacel, 
At the time of discharge 10 days later the ulcers 
dressed with honey had a cleaner wound bed, signs 
of infection had cleared and the green exudate had 
ceased, whereas with the Aquacell there was 
copious leakage of green fluid. 
44 
Multiple chronic leg 
ulcers, on both legs 
Ulcers had been there for >5 
years. They had features of 
stasis dermatitis. There was 
no arterial disease. 
The ulcers on one leg 
were dressed with honey, 
those on the other leg 
were debrided with 
fibrinolysin (Elase R) then 
dressed with Sorbosan R. 
Initially healing was much more rapid with honey. 
After I month both legs were healing well. 
74 
Broken-down wound 
from abdominal 
surgery 
Areas of dehiscence at each 
end of the wound, of similar 
appearance 
The dehiscence at one 
end was dressed with 
honey, on the other end 
with Debrisan. 
Healing was complete in 24 days with honey, 32 
days with Debrisan. 
75 
Third-degree burns 
to both arms 
 Burns on one arm were 
dressed with honey, the 
other arm with EUSOL. 
Granulation was “much nicer” with honey, reducing 
time to skin grafting. 
76 
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Table 4. Reports on the use of honey as a wound dressing: studies with multiple cases 
 
Type of wound Status of wounds before 
using honey 
No. of 
cases 
Outcome from treatment with honey Ref. 
no.  
16 acute traumatic wounds, 23 
complicated surgical wounds 
and 21 chronic non-responding 
wounds 
The chronic non-responding 
wounds had all been subjected 
to other regimens before honey 
dressings were used. 
60 One patient withdrew from the trial because the honey 
was causing pain. Two wounds did not change. The rest 
healed in a mean time of 3 weeks (range 1–28 weeks). 
One patient was treated with silver sulfadiazine and 
antibiotics instead of honey for one week because of an 
infection with Staphylococcus aureus. 
 
Advanced epithelialisation and a decrease in exudate, 
oedema and wound odour were observed. 
77 
Recalcitrant wounds and 
ulcers of varied aetiology, such 
as Fournier’s gangrene, burns, 
cancrum oris, diabetic ulcers, 
traumatic ulcers, decubitus 
ulcers, sickle cell ulcers and 
tropical ulcers 
47 of the patients had been 
treated for 1–24 months with 
conventional treatment (such as 
Eusol toilet and dressings of 
Acriflavine, Sofra-Tulle, or 
Cicatrin, or systemic and topical 
antibiotics) with no signs of 
healing, or the wounds were 
increasing in size. 
59 The 51 wounds with bacteria present became sterile within 
1 week and the others remained sterile. In one of the 
cases, a Buruli ulcer, treatment with honey was 
discontinued after 2 weeks because the ulcer was rapidly 
increasing in size. The 58 other cases “showed 
remarkable improvement”. Sloughs, necrotic and 
gangrenous tissue separated so that they could be lifted 
off painlessly, and were rapidly replaced with granulation 
tissue and advancing epithelialisation. Surrounding 
oedema subsided, weeping ulcers dehydrated, and foul-
smelling wounds were rendered odourless within 1 week. 
Burn wounds treated early healed quickly, not becoming 
colonised by bacteria. 
17 
 29 
Wounds from radical 
vulvectomy with 
lymphadectomy 
Wounds had broken down 12 Wounds became free from bacteria in 3–6 days. Complete 
healing was achieved in 3–8 weeks. Clean healthy 
granulation was achieved, requiring minimal surgical 
debridement. Skin grafting was unnecessary.  
13 
Wounds of mixed aetiology: 
surgical, accidental, infective, 
trophic, and burns. The 
average size of the wounds 
was 57 cm2. 
Half of the cases had been 
treated with “the usual topical 
measures” (an antiseptic) which 
had failed. One third of the 
wounds were purulent, the rest 
were red with a whitish coat. 
40 Honey delimited the boundaries of the wounds and 
cleansed the wounds rapidly to allow skin grafting. Of the 
33 patients treated only with honey dressings, 29 were 
healed successfully, with good quality healing, in an 
average time of 5–6 weeks. Two of the four who did not 
heal were suffering from immunodepression, one was 
withdrawn from treatment with honey because of a painful 
reaction to the honey, and one burn remained stationary 
after a good initial response. 
78 
Septic wounds, chronic ulcers, 
burns, pyogenic abscesses 
6 patients were diabetic, 5 with 
a septic foot and 1 with an 
abscess. 
11 Healing time was 7–15 days apart from one diabetic who 
took 56 days and one, who was ill, in which there was no 
improvement. Clean healthy granulation was achieved 
which allowed skin grafting in 14 days (30 for one 
diabetic), with prompt graft taking. 
18 
A variety of wounds, including 
ulcers of various aetiologies, 
pressure ulcers, burns, skin 
tears and traumatic wounds 
 20 In 80% of cases the wound bed improved (it was cleaner, 
with less slough and malodour, with movement along the 
healing continuum). In 20% of cases there was no 
improvement. 
65% found honey dressings easy to apply, 75% found 
them easy to remove, 85% found the dressings stayed in 
place, 65% found them comfortable. 
79 
 30 
Surgical wounds, mostly 
dehiscent or infected 
Pediatric patients receiving 
chemotherapy, making wounds 
hard to heal because of 
profound immunosuppression 
16 Wounds became sterile within 1–4 days. The average 
healing time was 25 days. Four patients undergoing 
prolonged immunosuppression healed in an average time 
of 27 days. Healing occurred without complication apart 
from one small keloid. 
41 
Venous leg ulcers that had 
undergone split-skin grafting 
Ulcers were of 12 months or 
more duration, and were not 
responding to normal treatment 
such as compression. They 
were of borderline suitability for 
grafts. Five had conditions 
characteristic of insufficient 
tissue perfusion. 
6 The mean healing time was 22 days. There were no post-
operative infections or other complications. No re-grafting 
or revision of grafts was needed. There was no recurrence 
of the ulcers on follow-up (average of 19 months later). 
80 
Fournier’s gangrene Honey was used following 
aggressive surgical debridement 
and triple antibiotic therapy. 
38 Honey gave rapid healing changes in an average period of 
10 days. 
81 
Gangrene in the genitals and 
perineum 
 14 The mean time for the debriding action of the honey to 
cleanse the wounds was 5.2 days, for granulation to be 
seen was 9.4 days, and for complete healing was 28.7 
days. 
82 
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Table 5. Reports on the use of honey as a wound dressing: studies of single cases 
 
Type of wound Status of wound before using honey Outcome from treatment with honey Ref. 
no.  
Bilateral leg ulcers of mixed 
aetiology 
88 year old patient with marked lower 
leg oedema and peri-wound maceration 
of skin 
Within 4 weeks there was a dramatic improvement in the 
maceration, and the ulcer beds were much healthier.* 
79 
Venous ulcer Five-year history of intermittent infected 
venous ulcers. The ulcer was inflamed, 
with necrosis, oedema and exudate. 
There had been no improvement with 4 
weeks of treatment with hydrogel. 
The exudate was decreased, so a compression stocking 
could then be used. The necrosis was debrided in 10 days. 
Complete healing was achieved in 28 weeks. The skin 
integrity had been maintained 18 months later. 
49 
Extensive leg ulcers 75 year old patient. Ulcers had 
increased in size over the past 4 years 
without signs of permanent healing 
despite ongoing attention. 
The foul smell disappeared. Granulation and islands of 
epithelialisation were seen within 3 weeks.* 
77 
Leg ulcers 85 year old patient with a history of 
numerous small sloughy leg ulcers not 
reducing in size despite 3-layer 
compression bandaging. There were 
calcium deposits subcutaneously and in 
the ulcer beds with associated chronic 
inflammation. The deposits had been 
removed by sharp debridement every 3 
months. 
After 2 weeks, atraumatic removal of the calcium deposits 
was occurring. This continued with further use of honey, with 
reduction in wound size, slough and inflammation.* 
83 
 32 
Hydroxyurea-induced leg ulcer 
on an immunosuppressed 
patient 
No change in the ulcer had occurred 
over three months of treatment with a 
range of topical therapies. It was 
sloughy, and MRSA was present. 
MRSA was cleared in 14 days. Healing was complete within 
21 days. Treatment with hydroxyurea and cyclosporin 
continued through this period. 
38 
Multiple bilateral venous ulcers 25 year history of venous ulceration 
with recurrent infections. Ulcers were 
deep, highly exuding, sloughy and 
malodorous. There was widespread 
varicose eczema in the region of the 
ulcers 
The malodour was removed within 1 day. After 10 days all 
signs of eczema had gone. But when compression 
bandaging was commenced there was within two days 
another outbreak of bacterial infection.* 
84 
Mixed arterial/venous ulcers on 
calf and median malleolus 
The ulcers, on an 80 year old patient, 
had occasionally shown signs of 
improvement in the past but they had 
never healed. Sharp debridement and 
removal of calcification was carried out 
before starting treatment with honey. 
After 4 weeks there was a 23.6% reduction in area of the 
large ulcer on the calf, and full epithelialisation of the small 
ulcer on the malleolus.* 
48 
 33 
Extensive venous ulcers The ulcers, on an 80 year old patient, 
were of 21/2 years duration, with 
compression being used. Recurrent 
infections had occurred, soon after 
each course of antibiotics had finished, 
that silver dressings did not prevent. 
The ulcers on one leg had got cellulitic, 
very wet, painful, and covered with soft 
necrotic tissue. They were debrided 
before starting treatment with honey. 
The ulcer on the other leg was clean 
but static and over-granulating 
Over the next 6 weeks no further infection occurred. (A low 
dose of Flucoxacillin was used for the first 3 weeks.) Then, 
coinciding with compression being started, infection recurred 
in the wet ulcers.* The over-granulating static ulcer on the 
other leg was healed, level with the skin, after 3 weeks 
treatment with honey. 
48 
Venous ulcer Painful, sloughy, highly exuding, 
malodorous. Initial debridement was 
done with maggots. 
Complete deodorisation was achieved within 24 hours.* 48 
Diabetic foot ulcers, 8 x 5 cm 
and 3 x 3 cm 
79 year old patient. The ulcers 
remained unhealed after 14 months 
treatment with an orthotic device, 
antibiotics, topical therapies by a wound 
care expert and four lots of surgery. 
MRSA, VRE and Pseudomonas were 
present in wound tissue. 
The ulcers were granulating within 2 weeks, and healed 
within 6 and 12 months. There had been no recurrence 2 
years later. 
40 
 34 
Pressure ulcer on ankle, 4 x 
2.5 cm, down to tendon 
83 year old patient. There was no 
commencement of healing when 
treated with SoloSite and hydrocolloids 
for 3 weeks. The ulcer was highly 
exudative, with a strong malodour, and 
painful. 
After 13 days there was much less malodour and less slough. 
The ulcer was healed in 11 weeks. 
85 
Sacral pressure ulcer 84 year old patient. The 5.5 x 5 cm 
ulcer had an area of necrosis 2 x 1 cm. 
The surrounding area was red and 
painful. There had been no 
improvement after 4 weeks of debriding 
treatment with SoloSite then a 
hydrocolloid then Solugel. 
The ulcer was debrided after 2 weeks, and was healed by 8 
weeks, almost without scarring. 
85 
Sacral pressure ulcer The ulcer was15–20 cm in size, 
exposing bone. 
The ulcer became closed, without surgery, after 21 days, and 
completely re-epithelialised in 10 weeks 
19 
Pressure ulcers There was one 10 x 5 cm ulcer, on the 
buttocks, with a deep centre, and two 
smaller ulcers. There was some 
discharge from the ulcers. 
Granulation was seen after 7 days. The smaller ulcers 
completely healed in 4 weeks, the larger one in 8 weeks. 
12 
Pressure ulcers The ulcer on one hip was deep. The 
large ulcer on the other hip and the 
linking ulcers in the sacral region had 
black slough. All ulcers were 
discharging and becoming offensive. 
The patient had disseminated sclerosis 
and was weak and ill. 
Within 6 weeks all slough had separated, there was no 
purulent discharge or malodour, and healthy granulation was 
seen at the edges of the ulcers. 
12 
 35 
Broken area of skin on calf The 6 x 2 cm wound, on an obese 
patient, was colonised, sloughy, with 
minimal exudate, and with a macerated 
peri-wound area 
Healed in 4 weeks 86 
Unhealed biopsy wound in 
groin 
Immunocompromised patient, with 
lymphoma, undergoing chemotherapy: 
wound at risk of becoming infected 
The wound was completely healed in 4 weeks. 39 
Non-healing split-thickness 
skin graft donor site 
The donor site was not healing 9 
months after a skin graft had been 
harvested. There was some over-
granulation, and moderate exudate. 
Healing was evident after 2 weeks, with exudate and pain 
reduced. Complete healing was achieved in 4 weeks. 
87 
Abscess following orthopaedic 
surgery 
The wound was unhealed 9 months 
after the surgery, despite courses of 
antibiotics and many types of dressings 
being tried. The abscess was 
recalcitrant, with a small amount of 
slough. 
After 4 weeks the surrounding redness was settling and there 
was some debridement. After a further 20 weeks the wound 
was the size of a pin-head, with no redness. 
87 
Lymphorrhoea in the groin 
resulting from a voluminous 
lymphocele following surgery 
on the iliac artery 
The patient refused the further surgery 
that was advised. 
Placing honey in the inguinal cavity daily reduced the liquid 
discharge to a minor amount within a few days, with a 
notable reduction in the size of the cavity. No discharge was 
occurring after 11 days.* 
88 
Cavity wounds from broken-
down haematomas, also 
infected split-thickness skin 
graft donor site 
There were two large wounds on the 
lower leg of an obese patient with 
chronic lymphoedema, on which skin 
grafting had failed. MRSA was present. 
The MRSA was eliminated, and complete healing was 
achieved in 8 weeks without further grafting, the donor sites 
healing first. Elimination of the offensive wound odour was 
also noted. 
 
37 
 36 
Broken-down wound from 
amputation of toe 
Amputation was because of gangrene 
in the big toe of an 83 year old patient. 
No improvement seen in the wound 
after 6 weeks of EUSOL and paraffin 
dressings. A hard crust, 2.5 x 4 cm, 
covered the wound. 
The crust started to separate and granulation was seen after 
7 days. By 2 weeks a lot of the crust had been removed and 
improvement in granulation had occurred.* 
12 
Recalcitrant wound in the 
axilla, from surgical treatment 
of hidradenitis suppurativa 
The wound had failed to heal for 36 
months despite trying a wide range of 
therapeutic dressings and systemic and 
topical antimicrobial agents and three 
attempts at treatment by surgery. 
There was removal of bacteria and a noticeable improvement 
in the wound in one week, and complete healing in one 
month. 
89 
Grossly infected wound from 
Caesarian section 
There was pus pouring from an open 
12 cm wound. Infection had not 
responded to several courses of 
antibiotics. 
The wound was clean and granulating after 7 days, and 
completely healed in 2 weeks. 
19 
Broken-down surgical wound 
after breast reduction 
Wound break-down started 6 weeks 
after surgery and deteriorated over the 
following 2 weeks. There was some 
granulation and some small areas of 
necrosis. The exudate was distressing. 
After 2 weeks the necrosis and slough had cleared, the 
malodour had gone, there was healthy granulation, and the 
exudate was manageable. There was complete healing in 13 
weeks. 
90 
Non-healing surgical wound The wound was not healing after 4 
weeks of daily dressing with calcium 
alginate. 
Complete healing was achieved in 6 weeks. 77 
Non-healing traumatic wound The 4 x 4 cm wound, on the lower arm, 
was clean but had no signs of 
granulation (no capillary buds were 
present). 
Granulation and epithelialisation were visible within 1 week, 
and complete healing was achieved in 6 weeks. 
37 
 37 
Extensive infected skin lesions 
resulting from meningococcal 
septicaemia 
 
These lesions had a heavy growth of 
Pseudomonas, Staphylococcus aureus 
and Enterococcus, and had remained 
non-healing for 8 months despite a 
wide range of treatments being tried. 
Additional lesions had resulted from 
graft donor sites becoming infected. 
Within a few days, signs of epithelialisation were seen, skin 
grafting became possible as the pathogens were cleared, 
and complete healing was achieved within 10 weeks. 
91 
Ulcer between breasts from 
radiation necrosis 
The wound had initially appeared 13 
months after mastectomy and 
radiotherapy and had then healed 13 
months after that, then had re-ulcerated 
a few months later and enlarged to 4 x 
3 cm with necrotic bone and costal 
cartilage at its base. The wound was 
painful, with thick, offensive pus 
exuding. The peri-wound area was sore 
and excoriated. 
Complete healing occurred in 10 months. 90 
Spontaneously erupted 
abscess (of unknown cause) 
on cheek 
After surgical drainage and antibiotics 
the lump arose again. 
After 3 lots of honey dressing of less than 24 hours each, on 
unbroken skin, the lump had reduced in size.* 
48 
Burn on upper arm 88 year old patient. The burn had dried 
out, but after 11/2 weeks of treatment 
with hydrogel the eschar was still dry, 
so the wound was tight and painful 
The eschar was softened within 1 week, so the wound 
became less painful. Debriding was occurring within 3 weeks 
and was complete within 10 weeks, with extensive 
epithelialisation.* 
79 
* Details of subsequent progress were not reported 
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Table 6. Animal experiments carried out on the use of honey as a wound dressing 
 
Type of 
wound 
Control 
treatment 
Species 
of animal 
No. in 
trial 
Results 
 
Statistics Other findings Ref. 
no. 
Complete epithelialisation achieved 
within 21 days with both honey and 
sugar, cf 28 - 35 days with silver 
sulfadiazine 
Not given Deep dermal 
burns (6.7 x 6.7 
cm) made with a 
170°C brass 
block 
Silver 
sulfadiazine: 
also  sugar 
Yorkshire 
pigs 
3 
(36 
wounds) 
Histological examination revealed less 
inflammation in wounds treated with 
honey than in those treated with sugar 
and with silver sulfadiazine, and a 
more advanced stage of healing. 
Not given 
 92 
First granulation was observed 
(histologically) after 5 days with 
honey, 10 days with the controls. 
Not given Dermal burns (1.3 
x 3 cm) made 
with a 170°C 
brass block 
Silver 
sulfadiazine: 
also 
untreated 
(other than a 
daily saline 
rinse) 
Pigs 2 
(27 
wounds) 
Less oedema and inflammation was 
observed (histologically) with honey 
than with the controls. 
Not given 
 93 
Third-degree 
dermal burns 
(made with 
steam), 8.5 cm2,, 
inoculated with 
Silver 
sulfadiazine : 
also acetate 
mafenid 
Piglets 60 After 30 days, the mean reduction in 
wound area was 62% with honey cf 
29% with silver sulfadiazine and 22% 
with acetate mafenid. 
p = 0.000 
for honey 
cf the 
other 
treatments 
 94 
 39 
After 10 days, the proportion of 
wounds with good granulation 
covering the major part, suitable for 
grafting, was 90% with honey cf 44% 
with silver sulfadiazine and 35% with 
acetate mafenid. 
p < 0.003 
for honey 
cf the 
other 
treatments 
The proportion of biopsy samples, 
taken after 10 days, giving positive 
microbial cultures was 20% with 
honey cf 100% with  silver 
sulfadiazine and 95% with acetate 
mafenid. 
p = 0.000 
for honey 
cf the 
other 
treatments 
The mean time to complete healing 
was 20.4 days with honey cf 30.3 
days with no treatment. 
p < 0.01 Superficial burns, 
created on the 
skin with a red-
hot pin (15 mm2) 
No treatment: 
also, solution 
of sugars as 
in honey 
Rats 60 
(120 
wounds) 
The mean time to complete healing 
was 20.4 days with honey cf 28.5 
days with sugar. 
p < 0.01 
Healing was seen 
histologically to be 
more active and 
advanced with honey, 
and honey was also 
clearly seen to give 
attenuation of 
inflammation and 
exudation, and less 
serious necrosis. 
16 
 40 
Wounds created 
by cutting away 2 
x 4 cm pieces of 
skin on the back 
Nitrofurazone
; also 
sterilised 
petrolatum 
Buffalo 
calves 
6 
(24 
wounds) 
Granulation, scar formation, and 
complete healing occurred faster with 
honey, with more proliferation of 
fibroblasts and angioblasts. 
Not given Attenuation of 
inflammation by 
honey was also seen 
(by histological 
observation). 
 
95 
Wounds created 
by cutting away 2 
x 4 cm pieces of 
skin on the back, 
infected by 
subcutaneous 
injection of 
Staphylococcus 
aureus two days 
prior to wounding 
Ampicillin 
ointment: 
also saline 
Buffalo 
calves 
9 
(90 
wounds) 
Honey gave the fastest rate of healing 
compared with the other treatments, 
also (observed histologically) the most 
rapid fibroblastic and angioblastic 
activity in the wounds and the fastest 
epithelialisation. 
Not given Attenuation of 
inflammation by 
honey was also seen 
(by histological 
observation). 
96 
Histological examination showed that 
the thickness of granulation tissue 
was greater with honey. 
p<0.001 Wounds created 
by excising skin 
(1 x 1 cm) 
Saline Mice 24 
Histological examination showed that 
the distance of epithelialisation from 
the edge of the wound was greater 
with honey. 
p<0.001 
 20 
 41 
The area of the wound (mm2) with the 
honey treatment cf the area with 
saline was: 
after 4 days: 47.5 cf 71.4 
after 8 days: 33.3 cf 52.2 
after 12 days: 9.1 cf 40.5 
p<0.01 Wounds created 
by excising skin 
(1 x 1 cm) 
Saline Rats 15 
(30 
wounds) 
The thickness of granulation tissue 
(mm, assessed histologically) with the 
honey treatment cf the thickness with 
saline was: 
after 4 days: 0.52 cf 0.389 
after 8 days: 1.17 cf 0.53 
after 12 days: 1.917 cf 0.995 
p<0.01 
With honey, 
epithelialisation was 
more rapid and there 
was less oedema 
(both assessed 
histologically). 
97 
Wounds created 
by excising skin 
(2 x 2 cm) 
Saline Rats 20 The mean contraction in size of the 
wounds was 80% with honey, 55% 
with saline. 
p = 0.001  98 
Wounds created 
by excising skin 
(2 x 2 cm) 
Saline Rats 20 After 10 days the mean area of the 
wounds was 1.15 mm2 with honey, 
2.38 mm2 with saline. 
p = 0.002 There was histological 
evidence of greater 
granulation with 
honey. 
99 
The quantity of collagen synthesised 
was increased by honey cf the control. 
p<0.001 Wounds created 
by excising skin 
(2 x 2 cm) 
No treatment Rats 12 
The degree of cross-linking of the 
collagen in the granulation tissue was 
increased by honey increased by 
honey cf the control 
p<0.05 
 100 
 42 
The content in granulation tissue of 
various markers of connective tissue 
metabolism increased by honey cf the 
control:  
 
protein 
collagen 
hexosamine 
uronic acid  
p<0.01 
p<0.01 
p<0.01 
p<0.001 
The rate of healing was increased 
by honey cf the control:  
 
Wounds created 
by excising skin 
(2 x 2 cm) 
No treatment Rats 12 
contraction of wound 
epithelialisation 
p<0.001 
p<0.05 
 101 
Incision (6 cm 
long) made in 
skin, then sutured 
No treatment Rats 12 The tensile strength of the wounds 
was increased by 21% with honey cf 
the control. 
p<0.05  101 
Honey increased the strength of the 
healed wounds compared with the 
untreated control:  
 
tensile strength (measured after 14 
days)  
p<0.001 
ultimate strength p<0.05 
Full-thickness 
incisions (3 cm 
long) made in the 
skin 
No treatment Rabbits 40 
yield strength p<0.02 
 
Less oedema was 
observed with the 
honey treatment, and 
histological 
examination revealed 
that honey gave less 
inflammation and 
necrosis and more 
fibroblasts and 
collagen present. 
102 
 43 
Full-thickness 
incisions (1.5 cm 
long) made in the 
skin 
No treatment Rats 6 Histological examination of biopsy 
samples showed: 
with honey, on Day 7 there was 
epithelial bridging cf inflammatory 
exudate and no epithelialisation 
with the control; 
with honey, on Day 14 there was 
complete epithelial bridging with 
honey cf epithelium yet to cover 
wound with the control. 
Not given  103 
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